Skip to main content
AI Market Summary
Loading market intelligence...

Hancock Jaffe Laboratories Inc (HJLI) Stock Forecast 2025 - AI Price Prediction & Analysis


Hancock Jaffe Laboratories Inc (HJLI) AI Stock Price Forecast & Investment Analysis

Hancock Jaffe Laboratories Inc Stock Price Chart and Technical Analysis

Loading Hancock Jaffe Laboratories Inc interactive price chart and technical analysis...

Hancock Jaffe Laboratories Inc (HJLI) - Comprehensive Stock Analysis & Investment Research

Deep dive into Hancock Jaffe Laboratories Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Hancock Jaffe Laboratories Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Hancock Jaffe Laboratories Inc: Hancock Jaffe Laboratories Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

Hancock Jaffe Laboratories Inc (Stock Symbol: HJLI) is a leading company in the Manufacturing sector , specifically operating within the Surgical and Medical Instrument Manufacturing industry.

The organization employs approximately 19 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Hancock Jaffe Laboratories Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Hancock Jaffe Laboratories Inc: With $1904M in annual revenue and 4.1% net margin, the company demonstrates developing profitability.

Annual Revenue: $1904 million generating a 4.1% net profit margin .

Market Capitalization: $478 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 4.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Hancock Jaffe Laboratories Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Hancock Jaffe Laboratories Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Hancock Jaffe Laboratories Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Hancock Jaffe Laboratories Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Hancock Jaffe Laboratories Inc: Strong free cash flow generation demonstrates solid operational efficiency.

Hancock Jaffe Laboratories Inc strategically competes in the highly dynamic Surgical and Medical Instrument Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $111 million annually.

The company maintains a healthy 18.9% gross margin, indicating strong pricing power and operational efficiency.

Hancock Jaffe Laboratories Inc (HJLI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Hancock Jaffe Laboratories Inc stock analysis.

Loading Hancock Jaffe Laboratories Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Hancock Jaffe Laboratories Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Hancock Jaffe Laboratories Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Hancock Jaffe Laboratories Inc: With a P/E ratio of 6.09, the market sees the stock as potentially undervalued.

P/E Ratio 6.09x
P/B Ratio 0.25x
Market Cap $478M
Dividend Yield 2.05%
EPS $1.60
Book Value/Share $39.68
Revenue/Share $38.86
FCF/Share $-7.26
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Hancock Jaffe Laboratories Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Hancock Jaffe Laboratories Inc: An ROE of 4.1% indicates room for improvement in shareholder value creation.

ROE 4.1%
ROA 2.8%
ROIC 3.8%
Gross Margin 18.9%
Operating Margin 6.3%
Net Margin 4.1%
EBT Margin 5.1%
Tax Rate 18.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Hancock Jaffe Laboratories Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Hancock Jaffe Laboratories Inc: A current ratio of 2.22 indicates strong liquidity.

Current Ratio 2.22x
Quick Ratio 1.17x
D/E Ratio 0.34x
Financial Leverage 1.61x
Interest Coverage 8.3x
Working Capital $6M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Hancock Jaffe Laboratories Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Hancock Jaffe Laboratories Inc: Free cash flow of $111M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $190M
Free Cash Flow $111M
Capital Spending $-80M
FCF/Sales 5.8%
CapEx/Sales 4.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Hancock Jaffe Laboratories Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Hancock Jaffe Laboratories Inc: An asset turnover of 0.67x suggests room for improvement in asset utilization.

Asset Turnover 0.67x
Receivables Turnover 7.2x
Inventory Turnover 4.7x
Fixed Assets Turnover 1.8x
Days Sales Outstanding 51 days
Days Inventory 77 days
Payables Period 37 days
Cash Conversion Cycle 92 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Hancock Jaffe Laboratories Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Hancock Jaffe Laboratories Inc: With annual revenue of $1904M, Hancock Jaffe Laboratories Inc operates at significant scale.

Income Statement ($ Millions)
Total Revenue $1904M
Operating Income $120M
Net Income $78M
R&D Expense $664M
SG&A Expense $13M
Cost of Goods Sold $81M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 25%
Cash & Short-term Investments 3%
Total Liabilities 38%
Short-term Debt 0%
Accounts Receivable 10%
Inventory 11%
Dividend & Shareholder Information
Dividends Per Share $0.20
Payout Ratio 12.5%
Shares Outstanding 49M

Latest Hancock Jaffe Laboratories Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Hancock Jaffe Laboratories Inc (HJLI) stock price and investment outlook.

, source: Orange County Business Journal

Irvine-based medical device maker Hancock Jaffe Laboratories Inc. (Nasdaq: HJLI) entered a sponsored research agreement for the development of its CoreoGraft product with Houston-based Texas Heart ...

, source: Insider Monkey

In this article we will analyze whether Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) is a good investment right now by following the lead of some of the best investors in the world and piggybacking ...

, source: Reuters

* HANCOCK JAFFE LABORATORIES INC SEES IPO OF 1.1 MILLION SHARES OF ITS COMMON STOCK VERSUS PREVIOUS VIEW OF ABOUT 1.9 MILLION SHARES - SEC FILING Sign up here. * HANCOCK JAFFE LABORATORIES INC ...

Hancock Jaffe Laboratories Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Hancock Jaffe Laboratories Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Hancock Jaffe Laboratories Inc Stock Forecast

How accurate are Hancock Jaffe Laboratories Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for HJLI predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Hancock Jaffe Laboratories Inc stock price forecasts?

Our analysis considers Hancock Jaffe Laboratories Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Hancock Jaffe Laboratories Inc a good investment in 2025?

Based on our AI analysis, Hancock Jaffe Laboratories Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Hancock Jaffe Laboratories Inc forecasts updated?

Hancock Jaffe Laboratories Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Hancock Jaffe Laboratories Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Hancock Jaffe Laboratories Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...